This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...

Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the ...

Efficiency and cost-effectiveness are key drivers in these recent developments in AI drug discovery and development, given that R&D for a new drug can take up to 18 years. The overarching desire ...

Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and approval ... overseeing AI applications in drug development, leading to uncertainty ...

Summary: The Food and Drug Administration (FDA) has recognized pharmacogenomics as an opportunity to identify new biomarkers that may expedite the drug development process. Currently, there are ...

28 the launch of Hyde Park Discovery, a collaboration aiming to advance the development of new medicines and other life-saving treatments ... will evaluate projects based on several criteria with the ...

Biosimulation Market size is expected to be worth around US$ 10.1 Billion by 2032 from US$ 303 Billion in 2023, growing at a CAGR of 13.7% ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

Professor of Pharmaceutics Paula & John J. Lovoi Sr. Endowed Professor in Drug Discovery and Development Director, Institute of Drug Education and Research Department of Pharmacological and ...

Pharmacokinetics is an area of pharmacology ... of drugs from biological systems in order to understand the effect of the drug, or of the organism, on the drug's impact. Pharmacokinetic parameters ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.